SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
-12.76%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$595M
AUM Growth
+$595M
(-6.8%)
Cap. Flow
+$31.7M
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
60.6%
Holding
37
New
6
Increased
11
Reduced
12
Closed
4
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$21.2M |
| 2 |
CVS Health
CVS
|
$17.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$16.9M |
| 4 |
Qiagen
QGEN
|
$14M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$9.57M |
Top Sells
| 1 |
Integra LifeSciences
IART
|
$22.3M |
| 2 |
Merck
MRK
|
$20.6M |
| 3 |
Baxter International
BAX
|
$14.3M |
| 4 |
SHPG
Shire pic
SHPG
|
$13.9M |
| 5 |
AstraZeneca
AZN
|
$7.24M |
Sector Composition
| 1 | Healthcare | 99.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Abbott
ABT
$231B
| $64.9M | 10.91% | 897,276 -85,036 | -9% | -$6.15M |
|
|
2
Bristol-Myers Squibb
BMY
$96B
| $58.7M | 9.86% | 1,128,470 +407,590 | +57% | +$21.2M |
|
3
Boston Scientific
BSX
$156B
| $46.2M | 7.77% | 1,308,374 -75,000 | -5% | -$2.65M |
|
|
4
Merck
MRK
$210B
| $35.2M | 5.92% | 461,046 -270,000 | -37% | -$20.6M |
|
|
5
Baxter International
BAX
$12.7B
| $32.2M | 5.42% | 489,628 -216,600 | -31% | -$14.3M |
|
6
Revvity
RVTY
$10.5B
| $28.2M | 4.74% | 359,081 -10,000 | -3% | -$786K |
|
7
Gilead Sciences
GILD
$140B
| $27.2M | 4.57% | 434,357 +111,170 | +34% | +$6.95M |
|
|
NUVA
8
DELISTED
NuVasive, Inc.
NUVA
| $23.5M | 3.95% | 473,923 +78,700 | +20% | +$3.9M |
|
9
Bio-Rad Laboratories Class A
BIO
$8.06B
| $22.5M | 3.78% | 96,697 | – | – |
|
|
SHPG
10
DELISTED
Shire pic
SHPG
| $21.9M | 3.68% | 125,656 -79,600 | -39% | -$13.9M |
|
11
Incyte
INCY
$16.5B
| $21.4M | 3.6% | 336,444 +122,680 | +57% | +$7.8M |
|
12
Agilent Technologies
A
$35.7B
| $21.3M | 3.57% | 315,051 +101,751 | +48% | +$6.86M |
|
|
13
Ionis Pharmaceuticals
IONS
$6.79B
| $20.5M | 3.45% | 379,421 +176,987 | +87% | +$9.57M |
|
14
Elevance Health
ELV
$71.8B
| $19.3M | 3.25% | 73,513 -10,000 | -12% | -$2.63M |
|
|
15
CVS Health
CVS
$92.8B
| $17.5M | 2.94% | +266,670 | New | +$17.5M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $16.9M | 2.83% | +263,000 | New | +$16.9M |
|
|
17
Qiagen
QGEN
$10.1B
| $14M | 2.36% | +407,406 | New | +$14M |
|
18
Perrigo
PRGO
$3.27B
| $11.9M | 2% | 306,820 -6,400 | -2% | -$248K |
|
19
Biogen
BIIB
$19.4B
| $9.96M | 1.67% | 33,100 -2,900 | -8% | -$873K |
|
|
PDCO
20
DELISTED
Patterson Companies, Inc.
PDCO
| $9.48M | 1.59% | 482,263 +4,556 | +1% | +$89.6K |
|
|
AGN
21
DELISTED
Allergan plc
AGN
| $9.36M | 1.57% | +70,000 | New | +$9.36M |
|
22
Cardinal Health
CAH
$35.5B
| $9.2M | 1.55% | 206,335 +70,000 | +51% | +$3.12M |
|
23
Universal Health Services
UHS
$11.6B
| $9.08M | 1.53% | 77,906 -27,106 | -26% | -$3.16M |
|
24
Dr. Reddy's Laboratories
RDY
$11.8B
| $6.46M | 1.09% | 171,219 | – | – |
|
25
McKesson
MCK
$85.4B
| $6.24M | 1.05% | +56,500 | New | +$6.24M |
|